;
Skip to main content
Home > Week in Review > Management

Chronological Index of : Management Tracks

 Current Issue
  • Adenium Biotech management update

    Adenium Biotech ApS, Copenhagen, Denmark Business: Infectious Hired: Edward Fang as CMO, formerly director of clinical sciences at Trius Therapeutics Inc., which Cubist Pharmaceuticals Inc. acquired

    Published on 9/22/2014
  • Alexion management update

    Alexion Pharmaceuticals Inc. (NASDAQ:ALXN), Cheshire, Conn. Business: Hematology, Neurology, Endocrine/Metabolic Hired: Edward Miller as SVP and chief compliance officer, a newly created position Promoted: Clare …

    Published on 9/22/2014
  • Alnylam management update

    Alnylam Pharmaceuticals Inc. (NASDAQ:ALNY), Cambridge, Mass. Business: Infectious, Endocrine/Metabolic, Cancer Hired: Karen Anderson as SVP and chief human resources officer, formerly VP of human resources for R&D and …

    Published on 9/22/2014
  • Antares management update

    Antares Pharma Inc. (NASDAQ:ATRS), Ewing, N.J. Business: Drug delivery Promoted: Robert Apple to COO, a newly created position, from EVP and president of the parenteral products group, while remaining CFO until a …

    Published on 9/22/2014
  • Array BioPharma management update

    Array BioPharma Inc. (NASDAQ:ARRY), Boulder, Colo. Business: Cancer, Inflammation, Chemistry Hired: Victor Sandor as CMO, formerly SVP of global clinical development at Incyte Corp.; he succeeds Michael Needle

    Published on 9/22/2014
  • Dimension Therapeutics management update

    Dimension Therapeutics, Cambridge, Mass. Business: Gene/Cell therapy, Hematology Hired: Annalisa Jenkins as CEO and a director, formerly EVP and head of global R&D at the Merck Serono S.A. biopharmaceutical division of …

    Published on 9/22/2014
  • E3XBio Inc. management update

    E3XBio Inc., Mill Valley, Calif. Business: Neurology Hired: Lori Rafield as CEO

    Published on 9/22/2014
  • Enumeral Biomedical management update

    Enumeral Biomedical Holdings Inc. (OTCQB:ENUM), Cambridge, Mass. Business: Cancer Hired: Kevin Sarney as VP of finance and chief accounting officer, formerly VP of finance and administration at Avaxia Biologics Inc.

    Published on 9/22/2014
  • Epizyme management update

    Epizyme Inc. (NASDAQ:EPZM), Cambridge, Mass. Business: Cancer Hired: Peter Ho as chief development officer

    Published on 9/22/2014
  • Galenica management update

    Galenica Ltd. (SIX:GALN), Bern, Switzerland Business: Pharmaceuticals Hired: Dario Eklund as head of international business operations at Galencia's Vifor Pharma Ltd. subsidiary, formerly VP at Organogenesis Inc.; and …

    Published on 9/22/2014
  • ImmunoGen management update

    ImmunoGen Inc. (NASDAQ:IMGN), Waltham, Mass. Business: Cancer Hired: Sandra Poole as SVP of technical operations, formerly SVP of biologics manufacturing at Sanofi's Genzyme Corp. subsidiary

    Published on 9/22/2014
  • Innate Pharma management update

    Innate Pharma S.A. (Euronext:IPH), Marseille, France Business: Cancer, Infectious, Inflammation Hired: Pierre Dodion as CMO; he succeeds Marcel Rozencweig, who becomes president of Innate's Innate Pharma Inc. U.S. …

    Published on 9/22/2014
  • Insulet management update

    Insulet Corp. (NASDAQ:PODD), Bedford, Mass. Business: Drug delivery, Endocrine/Metabolic Hired: Patrick Sullivan as president, CEO, and a director, formerly president, CEO and chairman of Cytyc Corp., which Hologic Inc.…

    Published on 9/22/2014
  • Ipsen management update

    Ipsen Group (Euronext:IPN; Pink:IPSEY), Boulogne-Billancourt, France Business: Cancer, Endocrine/Metabolic, Neurology Hired: Dennis Kim as SVP of North American medical and regulatory affairs, formerly VP and head of …

    Published on 9/22/2014
  • Ixico management update

    Ixico plc (LSE:IXI), London, U.K. Business: Diagnostic, Supply/Service Hired: Susan Lowther as CFO, effective Oct. 1, formerly CFO and a director of Novacyt S.A.

    Published on 9/22/2014
  • Merck KGaA management update

    Merck KGaA (Xetra:MRK), Darmstadt, Germany Business: Pharmaceuticals, Other Promoted: Stefan Oschmann, CEO of Merck's pharma division, to deputy CEO and vice chairman of the executive board, effective Jan. 1, 2015

    Published on 9/22/2014
  • Meta-IQ board of directors update

    Meta-IQ, Aarhus, Denmark Business: Ophthalmic, Autoimmune Appointed: Jarne Elleholm, CEO of Copenhagen Life Science Advisors, as chairman

    Published on 9/22/2014
  • Meta-IQ management update

    Meta-IQ, Aarhus, Denmark Business: Ophthalmic, Autoimmune Hired: Ingelise Saunders as CEO, formerly CEO of SLS Invest AB

    Published on 9/22/2014
  • Molecular Templates board of directors update

    Molecular Templates Inc., Georgetown, Texas Business: Proteomics, Cancer Appointed: Timothy Sullivan, partner at AJU Life Sciences Overseas Expansion Platform Fund

    Published on 9/22/2014
  • Nabsys management update

    Nabsys Inc., Providence, R.I. Business: Genomics Hired: Steve Lombardi as president, CEO and a director

    Published on 9/22/2014
  • Noxxon management update

    Noxxon Pharma AG, Berlin, Germany Business: Renal, Cancer, Hematology Hired: Don Munoz as CFO, a newly created position, formerly head of investment banking at Summer Street Research Partners

    Published on 9/22/2014
  • Nurix management update

    Nurix Inc., San Francisco, Calif. Business: Cancer Hired: Arthur Sands as CEO and a director, formerly president, CEO and a director of Lexicon Pharmaceuticals Inc.; he succeeds interim CEO Mark Goldsmith, who remains …

    Published on 9/22/2014
  • OncoSec management update

    OncoSec Medical Inc. (OTCQB:ONCS), San Diego, Calif. Business: Cancer Hired: Mai Le as CMO, formerly medical director at Calithera Biosciences Inc.; she succeeds Robert Pierce, who becomes CSO and global head of R&D, a…

    Published on 9/22/2014
  • OpsiRx board of directors update

    OpsiRx Pharmaceuticals Ltd., Cardiff, U.K. Business: Ophthalmic Appointed: Simon Turton as chairman, formerly head of European healthcare investments at Warburg Pincus LLC

    Published on 9/22/2014
  • OvaScience management update

    OvaScience Inc. (NASDAQ:OVAS), Cambridge, Mass. Business: Genitourinary Hired: Jeffrey Young as CFO, formerly CFO and treasurer of Transmedics Inc.

    Published on 9/22/2014

< Previous   1  2  3  4  5  Next >
Subscribe Now
Free Trial

About BioCentury

Decision-shaping business intelligence for the global biotech and pharma industry since 1993